Immunitybio Inc (IBRX)

Cost of Revenue

$298.00K

Quarterly · Period ending: · USD

IBRX logo

IBRX Cost of Revenue

Latest reported$298.00K
IBRX Quarterly Cost of Revenue ($0.00 → $298.00K)
High-resolution chart · PNG

IBRX cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Immunitybio Inc Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
298,000
238,000
4,247,000
4,128,000
136,000
58,000
0
0
0
0
0
0
0
6,278,000
6,878,000
5,975,000
5,931,000
5,408,000
0
0
0
0
2,247,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.